IRIS
SOLIMANDO, ANTONIO GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.010
AS - Asia 4.361
EU - Europa 3.337
SA - Sud America 1.134
AF - Africa 268
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 3
Totale 17.123
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.787
SG - Singapore 1.855
IT - Italia 970
BR - Brasile 895
CN - Cina 814
HK - Hong Kong 507
RU - Federazione Russa 447
SE - Svezia 414
DE - Germania 409
VN - Vietnam 358
FR - Francia 343
GB - Regno Unito 223
IN - India 160
FI - Finlandia 153
BD - Bangladesh 144
CA - Canada 123
ID - Indonesia 93
AR - Argentina 71
CI - Costa d'Avorio 67
ZA - Sudafrica 60
MX - Messico 58
IQ - Iraq 57
TR - Turchia 56
PL - Polonia 55
JP - Giappone 51
NL - Olanda 48
ES - Italia 44
CO - Colombia 43
PK - Pakistan 38
BE - Belgio 37
CZ - Repubblica Ceca 36
AT - Austria 31
VE - Venezuela 30
UA - Ucraina 28
EC - Ecuador 27
EG - Egitto 26
LT - Lituania 26
MA - Marocco 26
PH - Filippine 26
SA - Arabia Saudita 26
KR - Corea 24
JO - Giordania 22
TN - Tunisia 22
UZ - Uzbekistan 22
MY - Malesia 20
CL - Cile 19
KE - Kenya 17
PY - Paraguay 17
IE - Irlanda 16
AE - Emirati Arabi Uniti 15
ET - Etiopia 14
AU - Australia 10
DZ - Algeria 10
NP - Nepal 10
PE - Perù 10
BO - Bolivia 9
IR - Iran 9
CH - Svizzera 8
UY - Uruguay 8
JM - Giamaica 7
KW - Kuwait 6
LB - Libano 6
PA - Panama 6
AO - Angola 5
HU - Ungheria 5
NI - Nicaragua 5
OM - Oman 5
PS - Palestinian Territory 5
AZ - Azerbaigian 4
CR - Costa Rica 4
DK - Danimarca 4
HR - Croazia 4
IL - Israele 4
NO - Norvegia 4
RS - Serbia 4
SR - Suriname 4
SY - Repubblica araba siriana 4
AL - Albania 3
BG - Bulgaria 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
PT - Portogallo 3
QA - Qatar 3
SN - Senegal 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BF - Burkina Faso 2
EE - Estonia 2
GD - Grenada 2
GE - Georgia 2
GM - Gambi 2
GR - Grecia 2
HT - Haiti 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MG - Madagascar 2
ML - Mali 2
MT - Malta 2
Totale 17.084
Salva come PNG Salva come JPEG
Città #
Ashburn 1.111
Singapore 1.093
San Jose 606
Chandler 605
Fairfield 570
Hong Kong 501
Nyköping 341
Woodbridge 305
Beijing 269
New York 256
Houston 255
Seattle 252
Cambridge 234
Los Angeles 209
Bari 202
Ann Arbor 201
Wilmington 176
Council Bluffs 174
Lauterbourg 147
Dallas 142
Munich 114
Ho Chi Minh City 110
Helsinki 109
Dearborn 100
Roxbury 93
Lawrence 92
Boardman 88
Falkenstein 84
Marseille 84
São Paulo 82
Rome 73
Des Moines 71
Santa Clara 68
Abidjan 67
Brooklyn 67
Jakarta 67
Hanoi 66
Buffalo 65
Chicago 62
Frankfurt am Main 62
Moscow 60
Orem 47
London 46
Tokyo 46
San Diego 45
Nanjing 44
Montreal 42
Inglewood 40
Johannesburg 40
Dong Ket 39
Brussels 37
Toronto 37
Denver 36
Milan 36
Turku 36
Warsaw 32
Paris 31
Atlanta 29
Stockholm 29
Chennai 27
Brno 26
Phoenix 26
Jacksonville 24
Manchester 24
Poplar 24
Nuremberg 23
Redwood City 23
Baghdad 22
The Dalles 22
Rio de Janeiro 21
Amman 20
Boston 20
San Francisco 20
Tashkent 20
Washington 20
Guangzhou 19
Mexico City 19
Princeton 19
Campinas 18
Columbus 17
Salt Lake City 17
Shanghai 17
Curitiba 16
Dublin 16
Haiphong 16
Leawood 16
Dhaka 15
Tampa 15
Amsterdam 14
Augusta 14
Belo Horizonte 14
Elk Grove Village 14
Mumbai 14
Pune 14
Salvador 14
Shenyang 14
Brasília 13
Cairo 13
Kunming 13
Addis Ababa 12
Totale 10.770
Salva come PNG Salva come JPEG
Nome #
Adhesion-Mediated Multiple Myeloma (MM) Disease Progression: Junctional Adhesion Molecule a Enhances Angiogenesis and Multiple Myeloma Dissemination and Predicts Poor Survival 295
Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores the angiogenic homeostasis and suppresses tumor progression 244
Central Function for JAM-a in Multiple Myeloma Patients with Extramedullary Disease. 220
Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes 220
Bone marrow endothelial cells sustain a tumor-specific CD8+ T cell subset with suppressive function in myeloma patients 210
B-Cell Therapies in Relapsing Remitting and Primary Progressive Multiple Sclerosis: A Short Clinical Review 190
Early echocardiographic detection of left ventricular diastolic dysfunction in patients with systemic lupus erythematosus asymptomatic for cardiovascular disease 184
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment 183
CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer 181
The small subunit of Hemilipin2, a new heterodimeric phospholipase A2 from Hemiscorpius lepturus scorpion venom, mediates the antiangiogenic effect of the whole protein 179
Gene Expression Comparison between the Lymph Node-Positive and -Negative Reveals a Peculiar Immune Microenvironment Signature and a Theranostic Role for WNT Targeting in Pancreatic Ductal Adenocarcinoma: A Pilot Study 179
HB-EGF–EGFR Signaling in Bone Marrow Endothelial Cells Mediates Angiogenesis Associated with Multiple Myeloma 177
Emerging role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma 177
JAM-A as a Prognostic Factor and New Therapeutic Target in Multiple Myeloma 176
Microenvironment drug resistance in multiple myeloma: Emerging new players 175
Bone metastasis as primary presentation of pancreatic ductal adenocarcinoma: A case report and literature review 172
Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma 170
Targeting B-cell non Hodgkin lymphoma: New and old tricks 168
A multiple myeloma that progressed as type i cryoglobulinemia with skin ulcers and foot necrosis: A case report 164
Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview 161
JAM-A as a prognostic factor and new therapeutic target in multiple myeloma 158
Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study 157
Suspected Pericardial Tuberculosis Revealed as an Amyloid Pericardial Mass 156
A HGF/cMET autocrine loop is operative in multiple myeloma bone marrow endothelial cells and may represent a novel therapeutic target 153
Bortezomib treatment modulates autophagy in multiple myeloma 150
BL1391: an established cell line from a human malignant peripheral nerve sheath tumor with unique genomic features 150
Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma 149
Efficacy and safety of benralizumab in eosinophilic granulomatosis with polyangiitis: A meta‐analysis of eight studies 144
Inhibition of focal adhesion kinase overcomes resistance of mantle cell lymphoma to ibrutinib in the bone marrow microenvironment 144
A comprehensive biological and clinical perspective can drive a patient-tailored approach to multiple myeloma: Bridging the gaps between the plasma cell and the neoplastic niche 144
Insights into the Regulation of Tumor Angiogenesis by Micro-RNAs 140
Immune Checkpoint Inhibitor-Related Myositis: From Biology to Bedside 139
Short-Term Variations in Neutrophil-to-Lymphocyte and Urea-to-Creatinine Ratios Anticipate Intensive Care Unit Admission of COVID-19 Patients in the Emergency Department 139
circPVT1 and PVT1/AKT3 show a role in cell proliferation, apoptosis, and tumor subtype-definition in small cell lung cancer 138
Bortezomib Treatment Modulates Autophagy in Multiple Myeloma 137
Rhu-Epo down-regulates pro-tumorigenic activity of cancer-associated fibroblasts in multiple myeloma 137
Long‐term survival of an advanced colorectal cancer patient treated with Regorafenib: Case report and literature review 134
Imaging evaluation of pulmonary and non-ischaemic cardiovascular manifestations of covid-19 134
Dyspnea, Fatigue, and Generalized Weakness in a 67-Year-Old Man: Approach to the Patient Between Guidelines and Clinical Judgment 133
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma 133
Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib 132
Angiogenesis and Antiangiogenesis in Multiple Myeloma 132
Actors on the scene: Immune cells in the myeloma niche 132
Amyloid heart involvement lead a fast fatal evolution a healthy woman: a case report 131
Emerging Concepts in Acute Heart Failure: From the Pathophysiology to the Clinical Case Based Approach 131
Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers? 128
CIC-Mutation As a Potential Molecular Mechanism of Acquired Resistance to Combined BRAF/MEK Inhibition in CNS Multiple Myeloma 126
Cytotoxic t-lymphocyte antigen-4 in colorectal cancer: Another therapeutic side of capecitabine 126
A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery 125
CIC Mutation as a Molecular Mechanism of Acquired Resistance to Combined BRAF‐MEK Inhibition in Extramedullary Multiple Myeloma with Central Nervous System Involvement 125
Antibiotics or No Antibiotics, That Is the Question: An Update on Efficient and Effective Use of Antibiotics in Dental Practice 123
Bamlanivimab and Etesevimab administered in an outpatient setting for SARS-CoV-2 infection 122
RAL GTPases mediate multiple myeloma cell survival and are activated independently of oncogenic RAS 120
Cardiovascular risk in patients with Takayasu arteritis directly correlates with diastolic dysfunction and inflammatory cell infiltration in the vessel wall: a clinical, ex vivo and in vitro analysis. 119
Proangiogenic effect of bone marrow fibroblasts in patients with multiple myeloma 119
Case Report: Lymphocytosis Associated With Fatal Hepatitis in a Thymoma Patient Treated With Anti-PD1: New Insight Into the Immune-Related Storm 117
Exploration of Artificial Intelligence Use with ARIES in Multiple Myeloma Research 116
Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma 116
A t(4;13)(q21;q14) translocation in B-cell chronic lymphocytic leukemia causing concomitant homozygous DLEU2/miR15a/miR16-1 and heterozygous ARHGAP24 deletions 115
Antibiotic treatment in vasculitic leg ulcers: a single center experience 114
MicroRNAs as a Potential New Preventive Approach in the Transition from Asymptomatic to Symptomatic Multiple Myeloma Disease 113
Myeloma cells regulate miRNA transfer from fibroblast-derived exosomes by expression of lncRNAs 113
Folates dysmetabolism promotes atrial cardiomyopathy/fibrillation through a cardiac-bone marrow networking involving endothelial progenitor cell dysfunction and erythropoiesis diversion 112
Fever, cough and breathlessness in a patient with digeorge syndrome 112
A Challenging Case of Visceral Leishmaniasis 111
Sonography of superficial lymph nodes in malignant lymphomas. Data from our case series. 109
Two-year follow-up after drug desensitization in mucopolysaccharidosis 106
A Novel Automatic Algorithm to Support Lung Ultrasound Non-Expert Physicians in Interstitial Pneumonia Evaluation: A Single-Center Study 106
Right Heart Changes Impact on Clinical Phenotype of Amyloid Cardiac Involvement: A Single Centre Study 105
Telemedicine DSS-AI Multi Level Platform for Monoclonal Gammopathy Assistance 104
Rituximab induces a reduction of lymphocyte CD3+ activated in patients with autoimmune diseases 100
Induction therapy and stem cell mobilization in patients with newly diagnosed multiple myeloma 99
Prognostic role of neoplastic markers in Takotsubo syndrome 99
Real-life experience with omalizumab in chronic spontaneous urticaria. 98
Immune escape of multiple myeloma cells results from low miR29b and the ensuing epigenetic silencing of proteasome genes 97
Lung Ultrasound Is Useful for Evaluating Lung Damage in COVID-19 Patients Treated with Bamlanivimab and Etesevimab: A Single-Center Pilot Study 97
An atypical presentation of intestinal neuroendocrine tumor. 97
LIPIDS INCREASE IN HYPERTENSIVES DURING THE FIRST YEAR STEROID TREATMENT FOR GRANULOMATOSIS WITH POLYANGIITIS (GPA) 95
Breaking through Multiple Myeloma: A Paradigm for a Comprehensive Tumor Ecosystem Targeting 95
Epstein–Barr Virus in Salivary Samples from Systemic Lupus Erythematosus Patients with Oral Lesions 95
A Markov model for estimating the cost-effectiveness of immunotherapy for newly diagnosed multiple myeloma patients 95
Aplastic Anemia as a Roadmap for Bone Marrow Failure: An Overview and a Clinical Workflow 94
Identification and monitoring of Copy Number Variants (CNV) in monoclonal gammopathy 94
The bone marrow niche landscape: a journey through aging, extrinsic and intrinsic stressors in the haemopoietic milieu 94
Changes in Angiogenesis and Bone Turnover Markers in Patients with Gaucher Disease Developing Osteonecrosis 94
Genomic profiling at a single center cracks the code in inborn errors of immunity 93
CORRELATION BETWEEN VASCULAR INFLAMMATION MARKERS, DIASTOLIC DYSFUNCTION AND CARDIOVASCULAR RISK IN PATIENTS WITH TAKAYASU ARTERITIS 93
CARDIOVASCULAR RISK SCORE MAY BE USEFUL IN STRATIFY DEATH RISK IN HOSPITALIZED COVID19 PATIENTS 92
Comprehensive analysis of clinical outcomes, infectious complications and microbiological data in newly diagnosed multiple myeloma patients: a retrospective observational study of 92 subjects 89
Aggressive systemic mastocytosis with the co-occurrence of PRKG2::PDGFRB, KAT6A::NCOA2, and RXRA::NOTCH1 fusion transcripts and a heterozygous RUNX1 frameshift mutation 89
Complete Response of Synchronous Liver Metastasis in a Pancreatic Ductal Adenocarcinoma: Could Surgery Represent a Therapeutic Option? 89
Rituximab use in autoimmune diseases: a single center experience. 88
COVID-19 and the Endocrine System: A Comprehensive Review on the Theme 88
Immune system and bone microenvironment: rationale for targeted cancer therapies 88
Difference in growth hormone response to growth hormone-releasing hormone (GHRH) testing following GHRH subacute treatment in normal aging and growth hormone-deficient adults: Possible perspectives for therapeutic use of GHRH or its analogs in elderly subjects? 88
The anti-vegf(R) drug discovery legacy: Improving attrition rates by breaking the vicious cycle of angiogenesis in cancer 87
Gene Expression Comparison between Alcohol-Exposed Versus Not Exposed Pancreatic Ductal Adenocarcinoma Patients Reveals a Peculiar TGFβ-Related Phenotype: An Exploratory Analysis 86
Angiogenesis as Therapeutic Target in Metastatic Prostate Cancer – Narrowing the Gap Between Bench and Bedside 86
Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review 85
IMPACT OF REMOTE MONITORING ON PATIENTS’ QUALITY OF LIFE. A SINGLE CENTRE STUDY 85
Totale 13.023
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.555
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.555
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021129 0 0 0 0 0 0 0 0 0 0 0 129
2021/2022941 79 36 30 33 40 84 38 50 76 82 135 258
2022/20231.550 155 220 128 123 145 170 43 186 280 26 50 24
2023/2024866 48 121 54 76 75 258 32 21 20 24 16 121
2024/20253.613 150 57 172 130 134 313 538 355 160 220 522 862
2025/20267.962 1.066 374 498 903 1.019 483 904 312 1.033 813 448 109
Totale 18.061